HAS-BLED Calculator
Estimate one-year major bleeding risk with the HAS-BLED score before anticoagulation in atrial fibrillation.
What Is the HAS-BLED Score?
HAS-BLED estimates one-year major bleeding risk in patients with atrial fibrillation who may receive anticoagulation. It flags modifiable bleeding risk factors rather than excluding patients from therapy. Pair it with stroke risk tools such as the CHA2DS2-VASc Calculator when balancing thromboembolic and bleeding risks.
The Nine HAS-BLED Criteria
Each present criterion adds one point: uncontrolled hypertension (SBP above 160 mmHg), abnormal renal function, abnormal liver function, prior stroke, prior major bleeding, labile INR on warfarin, age 65 or older, alcohol use of at least 8 drinks per week, and concomitant drugs that increase bleeding (antiplatelets or NSAIDs).
Interpreting the Total Score
A score of 0 indicates low bleeding risk (about 0.9% annual major bleeding, roughly 1.1 events per 100 patient-years). Scores of 1 to 2 suggest moderate risk where anticoagulation may still be reasonable. Scores of 3 or higher indicate high risk and warrant closer follow-up, INR monitoring when applicable, and correction of reversible factors.
Clinical Use
HAS-BLED should be calculated before starting anticoagulation. High scores do not automatically contraindicate therapy when stroke risk is substantial. Instead, they prompt vigilance and interventions on reversible items such as blood pressure control, alcohol reduction, and medication review.
Frequently Asked Questions
Does a high HAS-BLED score mean no anticoagulation?
Not necessarily. HAS-BLED identifies bleeding risk so clinicians can monitor closely and address reversible factors while still treating stroke risk when appropriate.
What counts as labile INR?
Labile INR typically means time in therapeutic range below about 60% while on oral anticoagulation, with frequent out-of-range measurements.
Why is hypertension scored only above 160 mmHg?
The original HAS-BLED definition awards a point when systolic blood pressure exceeds 160 mmHg, reflecting poorly controlled hypertension rather than a diagnosis alone.
What is major bleeding in this context?
Major bleeding includes fatal bleeding, clinically overt bleeding with hemoglobin drop of at least 20 g/L, transfusion of two or more units, or bleeding in a critical anatomic site.
Can I use this for direct oral anticoagulants?
HAS-BLED was developed in anticoagulated atrial fibrillation cohorts and remains widely used before starting any anticoagulant, though INR-related points apply mainly to warfarin-treated patients.